Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.6611.3414.7129.3720.80

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 8.66 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.66
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.66
-23.63
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹852.3 Cr -6.4% -18.6% 116.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-6.4%

-18.6%

116.2%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses